fixed costs, while sales that increased from business growth will gradually be recognized as revenue per the accounting standard. 2. Total expenses of Baht 41.50 million, a decrease by Baht 217.18 million

8,875m, increased by 128% YoY. Major drivers of such growth were 298% increase in revenue from sales of house and condominium together with 38% increase in revenue from rental and services which mainly

22.68% of the same period of previous year). The profit margin increased from the same period of previous year mainly because the significant growth in revenue. Due to large portion of fixed costs, the

its overseas subsidiaries’ operation as well as continuing marketing and managing expense to support existing customers despite of reduced in sales growth as compared. 4. Financial Cost For the third

/2017 (for the equity holders of the Company) was THB 36.65 million, an increase of THB 8.85 million or of 31.83% from the same period last year (Q3/2017 : THB 27.80 million). The Growth in revenues and

-47.86 million, Baht - 50.16 million and Baht -29.12 million in Q1, Q2 and Q3 2017 respectively. Considering the sustainable growth, the company is in the process of launching the new business concept with

the main trading currency of the company), resulting in the company recognized revenue from sales of foreign currency decreased For domestic market, revenue from sales increase lightly due to growth of

shares of Pek Industries Co., Ltd. at Baht 800.80 per share, totally Baht 5,600,000 for managing excess liquidity and gaining opportunity to invest in new business expecting good business growth. 10

opportunity to invest in new business expecting good business growth. 10) Opinions by Audit Committee - None - 11) Transaction Type : The Transaction as stated above would be within scope of the related

, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the